We are thrilled to announce that RxE2 has once again been recognized by The Tech Tribune as one of the Best Tech Startups in North Dakota for 2025! This prestigious award marks our fourth consecutive year on this esteemed list, following our consistent inclusion in 2022, 2023, and 2024
- Revenue potential
- Leadership team
- Brand/product traction
- Competitive landscape
At RxE2, our core mission is to improve the way clinical trials are managed, making them more efficient and effective to drive more drugs to the market faster. We achieve this by leveraging the power of community pharmacists, providing them with powerful and cutting-edge technology to help pharmaceutical companies overcome significant challenges in clinical trials. These challenges traditionally include patient recruitment (in terms of time and diversity), patient engagement and retention (adherence to protocol, dropout rates), and the logistics of drug dispensing and counseling. RxE2 is entirely revolutionizing how clinical trials are conducted by introducing community-based trials, powered by our technology that provides patient recruitment, dispensing, counseling, and operational services to the pharmaceutical and biotech industries.
About the Tech Tribune and the Best Tech Startups list
Founded in 2017, The Tech Tribune is a leading platform that delivers the latest technology news, in-depth technology articles, exclusive interviews with entrepreneurs, and insights on the hottest technology startups from around the world. Their flagship journalistic endeavor, the “Best Tech Startups” series, is published annually for every major city and state in the US, and for the US as a whole.
Their mission is to recognize and honor the most exemplary young companies all across the country, particularly those that often do not get a well-deserved turn in the spotlight.
